蜂毒注射对帕金森病的有效性:系统性审查
Hyein Jeong1, Kyeong Han Kim2, Seong-Gyu Ko1
1Department of Science in Korean Medicine, College of Korean Medicine, Kyung Hee University, Seoul 02446, Republic of Korea.
Toxins
|April 25, 2025
概括
蜂毒针 (BVA) 显示出治疗帕金森病 (PD) 的前景,研究表明症状改善和轻微的副作用. 这种自然疗法为PD管理提供了潜在的替代方案.
科学领域:
- 神经科学是一个神经科学.
- 整合和补充医学是整合和补充医学.
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,影响全球数百万人.
- 目前用于PD的药理疗法可能会导致长期的副作用,如动力障碍.
研究的目的:
- 系统地审查蜜蜂毒针 (BVA) 治疗帕金森病的疗效和安全性.
- 评估BVA作为PD补充疗法的潜力.
主要方法:
- 在2025年2月,对8个数据库进行了全面搜索.
- 该综述包括12项涉及215名帕金森病患者的研究,这些患者接受了BVA治疗.
- 统一的帕金森病评级尺度是跨研究的共同结果衡量标准.
主要成果:
- 所有包括的研究都报告了PD患者接受BVA治疗的各种结局措施的改善.
- 轻微的不良反应,如局部胀和,在33.3%的研究中观察到.
- 没有报告严重的不良事件,包括过敏性休克.
结论:
- 蜂毒针在改善与帕金森病相关的症状方面显示出潜在的有效性.
- BVA似乎是PD相对安全的治疗选择,轻微副作用的发生率很低.
- 进一步的临床研究可能会支持BVA在帕金森病管理中的更广泛应用.
相关概念视频
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Parkinson's Disease: Overview
310
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
310


